Clinical Trial Update: Biomarker-based Study in R/M SCCHN [Phase 2]

View source ↗

Summary

Phase 2 biomarker-based study in recurrent/metastatic squamous cell carcinoma of the head and neck is ongoing with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 2 | Status: UNKNOWN